EDGAR Filing Documents for 0000950170-24-113297

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000950170-24-113297

Filing Date

2024-10-07

Accepted

2024-10-07 17:00:19

Documents

Period of Report

2024-10-04

Document Format Files

Seq	Description	Document	Type	Size
1	4	ownership.html	4
1	4	ownership.xml	4	3884
	Complete submission text file	0000950170-24-113297.txt		5376

Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618

Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203

CG Oncology, Inc. (Issuer) CIK: 0001991792 (see all company filings)

IRS No.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CG ONCOLOGY, INC. 400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CA 92618

Business Address

Bellete Ambaw (Reporting) CIK: 0002007090 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41925 | Film No.: 241358432